par Coussement, Gauthier;Catherine, Julien ;Roufosse, Florence
Référence Journal of leukocyte biology, 116, 5, page (1021-1032)
Publication Publié, 2024-11-01
Article révisé par les pairs
Titre:
  • Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program.
Auteur:Coussement, Gauthier; Catherine, Julien; Roufosse, Florence
Informations sur la publication:Journal of leukocyte biology, 116, 5, page (1021-1032)
Statut de publication:Publié, 2024-11-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:anti-IL-5
compassionate use
hypereosinophilic syndrome
mepolizumab
MeSH keywords:Humans
Hypereosinophilic Syndrome -- drug therapy
Antibodies, Monoclonal, Humanized -- therapeutic use -- adverse effects -- administration & dosage
Male
Female
Middle Aged
Adult
Aged
Retrospective Studies
Compassionate Use Trials
Treatment Outcome
Interleukin-5 -- antagonists & inhibitors
Langue:Anglais
Identificateurs:urn:issn:0741-5400
info:doi/10.1093/jleuko/qiae152
info:pii/7708691
info:pmid/38970502